Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Camargo Pharmaceutical Services, LLC, a leading drug development and commercial partner, announced today it will acquire Paidion Research, Inc., a...
Clinical-stage cannabinoid development company Incannex Healthcare Limited (ASX: IHL) has announced its plans to request an expedited pre-IND meeting ...
Camargo Pharmaceutical Services, LLC, a global drug development and commercial partner, announced today the appointment of Jennie Orr as Chief...
Camargo Pharmaceutical Services, LLC, a global drug development and commercial partner, announced today the appointment of Reeves McGee as Chief...
CINCINNATI, Aug. 31, 2020 /PRNewswire/ – Camargo Pharmaceutical Services, LLC, a global drug development and commercial partner, announced today the...
Camargo Pharmaceutical Services, LLC, congratulates Chiasma, Inc. on obtaining approval from the US Food and Drug Administration for MYCAPSSA®...
Camargo Pharmaceutical Services, a leading drug development and commercialization partner, announced today it will acquire InSymbiosis, a Canadian...
Camargo Pharmaceutical Services, a leading drug development and commercialization partner, announced today that Ruth Stevens, PhD, MBA, co-founder...
Camargo Pharmaceutical Services, an industry-leading drug development and commercialization services company, today announced it will expand its...
In response to strong interest from Asian pharmaceutical companies seeking access to U.S. markets, Cincinnati-based Camargo Pharmaceutical Services'...
Quivive ('kee-veev') Pharma ("Quivive" or the "Company"), a San Diego-based biotechnology company developing next generation opioid therapies...
Camargo Pharmaceutical Services, LLC ("Camargo" or the "Company") announced today that the Company has received a significant growth investment from...
Impel NeuroPharma ("Impel" or the "Company"), a Seattle-based clinical stage biotechnology company developing first-in-class intranasal drug...
Camargo Pharmaceutical Services, the most experienced global strategist in 505(b)(2) drug development, announces the addition of a former Food and...
Camargo Pharmaceutical Services, the most experienced global strategist in the drug development industry specializing in the 505(b)(2) approval...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.